Aliases & Classifications for Vestibular Disease

MalaCards integrated aliases for Vestibular Disease:

Name: Vestibular Disease 12 15 17
Vestibular Diseases 44 72
Vertigo, Vestibular Disorder 12
Diseases of Inner Ear 72
Vestibular Disorder 55

Classifications:



External Ids:

Disease Ontology 12 DOID:3426
MeSH 44 D015837
SNOMED-CT 68 20425006
ICD10 33 H81 H81.9 H81.90
UMLS 72 C0042594 C0494559

Summaries for Vestibular Disease

MalaCards based summary : Vestibular Disease, also known as vestibular diseases, is related to meniere disease and vestibular neuronitis, and has symptoms including vertigo and vertigo/dizziness. An important gene associated with Vestibular Disease is COCH (Cochlin), and among its related pathways/superpathways is Gap junction trafficking. The drugs Caffeine and Prednisolone phosphate have been mentioned in the context of this disorder. Affiliated tissues include testes, brain and eye, and related phenotypes are behavior/neurological and hearing/vestibular/ear

Related Diseases for Vestibular Disease

Diseases related to Vestibular Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 206)
# Related Disease Score Top Affiliating Genes
1 meniere disease 32.3 FAM136A COCH AQP2
2 vestibular neuronitis 30.7 SALL1 RTEL1
3 deafness, autosomal dominant 9 30.6 FAM136A COCH
4 superior semicircular canal dehiscence 30.5 RTEL1 COCH
5 congenital cytomegalovirus 30.1 GJB6 GJB2
6 deafness, autosomal recessive 4, with enlarged vestibular aqueduct 29.8 SLC26A4 KCNJ10 GJB6 GJB3 GJB2 FOXI1
7 ear malformation 29.7 SLC26A4 KCNJ10 GJB2 FOXI1
8 motion sickness 29.6 FAM136A AVP
9 cogan syndrome 29.4 GJB2 CRLF1
10 nonsyndromic deafness 29.2 SLC26A4 GJB6 GJB3 GJB2 FOXI1 COCH
11 sensorineural hearing loss 28.3 SLC26A4 GJB6 GJB3 GJB2 COCH ATP6V1B1
12 auditory system disease 27.7 SLC26A4 RTEL1 GJB6 GJB3 GJB2 COCH
13 inner ear disease 27.7 SLC26A4 RTEL1 GJB6 GJB3 GJB2 FOXI1
14 peripheral vertigo 26.7 SLC26A4 RTEL1 OTOL1 KCNE3 FAM136A CRLF1
15 hypotrichosis-deafness syndrome 10.6 GJB3 GJB2
16 deafness, autosomal recessive 93 10.6 GJB3 GJB2
17 deafness, autosomal dominant 36 10.6 SLC26A4 GJB2
18 deafness, autosomal recessive 28 10.6 GJB3 GJB2
19 deafness, autosomal recessive 26 10.5 SLC26A4 GJB2
20 deafness, autosomal dominant 24 10.5 GJB6 GJB2
21 mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma 10.5 GJB3 GJB2
22 deafness, autosomal dominant 6 10.5 SLC26A4 GJB2 COCH
23 knuckle pads, leukonychia, and sensorineural deafness 10.5 GJB6 GJB2
24 deafness, autosomal dominant 13 10.5 SLC26A4 GJB2 COCH
25 deafness, x-linked 2 10.4 GJB6 GJB2
26 dfnb1 10.4 GJB6 GJB2
27 vohwinkel syndrome 10.4 GJB6 GJB2
28 deafness, autosomal recessive 30 10.4 SLC26A4 GJB2
29 drug-induced hearing loss 10.4 SLC26A4 GJB3 GJB2
30 inappropriate adh syndrome 10.4 AVP AQP2
31 autosomal recessive nonsyndromic deafness 10.4 SLC26A4 GJB2
32 obstructive hydrocephalus 10.3 GJB6 CRLF1
33 deafness, autosomal recessive 23 10.3 SLC26A4 GJB6 GJB2
34 deafness, autosomal dominant 2a 10.3 GJB6 GJB2 COCH
35 branchiootic syndrome 1 10.3
36 autosomal recessive nonsyndromic deafness 3 10.3 SLC26A4 GJB2
37 impaired renal function disease 10.3 AVP AQP2
38 pathologic nystagmus 10.3
39 kid syndrome 10.3 GJB6 GJB3 GJB2
40 pseudoainhum 10.3 GJB6 GJB3 GJB2
41 deafness, autosomal recessive 1a 10.3 GJB6 GJB3 GJB2
42 knuckle pads 10.3 GJB6 GJB3 GJB2
43 vestibulocochlear nerve disease 10.3 SALL1 RTEL1
44 erythrokeratodermia variabilis et progressiva 1 10.3 GJB6 GJB3 GJB2
45 brain compression 10.3 GJB6 AVP
46 clouston syndrome 10.2 GJB6 GJB3 GJB2
47 syndrome of inappropriate antidiuretic hormone 10.2 AVP AQP2
48 sphenoid sinusitis 10.2 GJB6 AVP
49 neuritis 10.2
50 plexopathy 10.2 CRLF1 AVP

Graphical network of the top 20 diseases related to Vestibular Disease:



Diseases related to Vestibular Disease

Symptoms & Phenotypes for Vestibular Disease

UMLS symptoms related to Vestibular Disease:


vertigo, vertigo/dizziness

MGI Mouse Phenotypes related to Vestibular Disease:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.97 AQP2 ATP6V1B1 AVP CRLF1 FOXI1 GJB6
2 hearing/vestibular/ear MP:0005377 9.91 ATP6V1B1 COCH FOXI1 GJB2 GJB6 KCNE3
3 homeostasis/metabolism MP:0005376 9.9 AQP2 ATP6V1B1 AVP FOXI1 GJB2 GJB3
4 nervous system MP:0003631 9.7 ATP6V1B1 AVP CRLF1 FOXI1 GJB2 GJB6
5 renal/urinary system MP:0005367 9.17 AQP2 ATP6V1B1 AVP FOXI1 KCNJ10 SALL1

Drugs & Therapeutics for Vestibular Disease

Drugs for Vestibular Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 72)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Caffeine Approved Phase 4 58-08-2 2519
2
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
3
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
4
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
5
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
6
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
7
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
8 Neurotransmitter Agents Phase 4
9 Central Nervous System Stimulants Phase 4
10 Purinergic P1 Receptor Antagonists Phase 4
11 Phosphodiesterase Inhibitors Phase 4
12 Anti-Inflammatory Agents Phase 4
13 Peripheral Nervous System Agents Phase 4
14 Autonomic Agents Phase 4
15 Gastrointestinal Agents Phase 4
16 Antiemetics Phase 4
17 Neuroprotective Agents Phase 4
18 glucocorticoids Phase 4
19 Hormones Phase 4
20 Respiratory System Agents Phase 4
21 Methylprednisolone Acetate Phase 4
22 Protective Agents Phase 4
23 Antineoplastic Agents, Hormonal Phase 4
24 Hormone Antagonists Phase 4
25 Anti-Asthmatic Agents Phase 4
26 Betamethasone Valerate Phase 4 2152-44-5
27 Betamethasone sodium phosphate Phase 4
28 Betamethasone-17,21-dipropionate Phase 4
29 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4
30 Betamethasone benzoate Phase 4
31 Prednisolone acetate Phase 4
32
Lamotrigine Approved, Investigational Phase 3 84057-84-1 3878
33
Calcium Approved, Nutraceutical Phase 3 7440-70-2 271
34 Tranquilizing Agents Phase 3
35 Diuretics, Potassium Sparing Phase 3
36 Sodium Channel Blockers Phase 3
37 Psychotropic Drugs Phase 3
38 Antipsychotic Agents Phase 3
39 Anticonvulsants Phase 3
40 Central Nervous System Depressants Phase 3
41 calcium channel blockers Phase 3
42 Calcium, Dietary Phase 3
43
Prednisone Approved, Vet_approved Phase 2 53-03-2 5865
44
Propranolol Approved, Investigational 525-66-6 4946
45
Promethazine Approved, Investigational 60-87-7 4927
46
Ondansetron Approved 99614-02-5 4595
47
Lorazepam Approved 846-49-1 3958
48
Meclizine Approved 569-65-3 4034
49
Diazepam Approved, Illicit, Investigational, Vet_approved 439-14-5 3016
50
Diphenhydramine Approved, Investigational 58-73-1, 147-24-0 3100

Interventional clinical trials:

(show top 50) (show all 89)
# Name Status NCT ID Phase Drugs
1 Effect of Caffeine Intake in Vestibular Function: A Randomized Triple-Blind Controlled Trial Completed NCT02825199 Phase 4
2 Acute Unilateral Vestibulopathy and Corticosteroid Treatment Suspended NCT02912182 Phase 4 Betamethasone;Placebo;Prednisolone
3 Conventional Versus Virtual Reality Based Vestibular Rehabilitation; Effect on Dizziness, Gait and Balance Completed NCT01442623 Phase 2, Phase 3
4 Lamotrigine for Ménière's Disease: a Double-blind, Placebo-controlled Pilot Study Completed NCT02158585 Phase 3 Lamotrigine;Placebo
5 Visual Feedback Goggle For The Treatment Of Benign Paroxysmal Positional Vertigo in a Randomized Single-Blind Study Unknown status NCT00729885 Phase 1, Phase 2
6 Prednisone Treatment for Vestibular Neuronitis Completed NCT00271791 Phase 2 Prednisone;Prednisone
7 Vestibular Therapy in Alzheimer's Disease Not yet recruiting NCT03799991 Phase 1, Phase 2
8 Prospective, Randomized, Placebo-controlled, Phase 2 Study of 4-aminopyridine, Atenolol, or Placebo in the Treatment of Patients With Vestibular Migraine Withdrawn NCT03578354 Phase 2 4-aminopyridine;Atenolol
9 Evaluation of a Vibrotactile Sensory Aid Developed by the US Navy to Combat Pilot Disorientation as a Prosthesis in Patients With Postural Imbalance and Spatial Disorientation Unknown status NCT00146952 Phase 1
10 Physiotherapy in Vestibular Disorders Unknown status NCT02746770
11 Biological Rhythms and Vestibular System Unknown status NCT01839409
12 Vestibular and Multisensory Influence on Bodily and Spatial Representations. Behavioral and Electrophysiological Investigations in Vestibular-defective Patients and Healthy Volunteers Unknown status NCT02072460
13 Clinical Utility of Simultaneous Recordings of Cervical and Ocular Vestibular-evoked Myogenic Potentials During Monaural Stimulation Unknown status NCT03049683
14 The Liberatory Maneuver for the Treatment of Benign Paroxysmal Positional Vertigo: A Randomized Controlled Trial Unknown status NCT01008124
15 Comorbidity Between Balance and Childhood Anxiety: Treatment of Anxiety by Training of Balance Unknown status NCT00599742
16 Endothelial Dysfunction in Hyperemesis Gravidarum Unknown status NCT02989337
17 Neural Mechanisms Engaged in Control of Eye Movements Unknown status NCT00999934
18 Comparison of Clinical and Game-based Rehabilitation for Balance Impairments and Gaze Dysfunction in Clients With Vestibular Disorders Unknown status NCT02134444
19 Evaluation of the Sensorial Preference for Balance Control Unknown status NCT01146249
20 The Assessment and Treatment of Balance Impairment Using Virtual Reality (VR) in Panic Disorder Patients Unknown status NCT01677429
21 Cawthorne Cooksey Versus Vestibular Habituation Exercises on Trunk Kinetics and Velocity of Gait in Patients With Multiple Sclerosis Completed NCT03670459
22 Study of Rotatory Vestibular Tests in Major Depression Patients and Healthy Control Subjects. Completed NCT03421847
23 Efficacy Of Biofeedback Training And Whole Body Vibration Therapy In Vestibular Rehabilitation Of Unilateral Vestibular Weakness Completed NCT03973255
24 Evaluation Of Vestibular Functions and Balance in Edirne Band Musicians Completed NCT03915353
25 Effects of a Virtual Reality-based Dual-task Exercise on Vestibular Function in Healthy Community Dwellers. A Pilot Study Completed NCT03160352
26 The Effects of Vibrotactile Feedback During Vestibular Rehabilitation Completed NCT02867683
27 Head-Mounted Vibrotactile Prosthesis for Patients With Chronic Postural Instability Completed NCT03330262
28 Impact Des déficits Vestibulaires Sur le développement Des Fonctions Visuo-spatiales. Completed NCT02533739
29 Diagnostic Accuracy of the Vibration Induced Nystagmus Test in Room Light. Completed NCT02626052
30 Vestibular Rehabilitation and Dizziness in Geriatric Patients Completed NCT01729039
31 Clinical Randomized Trial to Evaluate the Efficacy of Vestibular Stimulation as Coadjuvant Therapy in Major Depression Completed NCT01399671
32 Gaze and Movement Behavior of Patients With Vestibular Dysfunction During Level Floor, Ramp, and Stair Walking Completed NCT02417545
33 Assessment of Visual Sensitivity, Psychiatric Profile and Quality of Life Following Vestibular Schwannoma Surgery in Patients Prehabituated by Chemical Vestibular Ablation Completed NCT03638310
34 Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular Dysfunction Completed NCT00004366
35 Effects of Vestibular Rehabilitation in the Treatment of Patients With Acute Vestibular Loss. - A Randomized Controlled Trial Completed NCT00702832
36 Effectiveness of Additional Protocol Exercises for Cervical Mobility and Proprioception in Vestibular Rehabilitation: a Randomized Controlled Trial Completed NCT02622516
37 Quality of Life and Dynamic Visual Acuity in Patients With Bilateral Vestibulopathy: the Impact of Covert-saccades Completed NCT02753179
38 Unilateral Peripheral Vestibular Dysfunction: Reeducation and Spatial Orientation. Completed NCT03171181
39 Functional Link Between Hippocampal and Vestibular Systems: a Pilot Study in Epilepsy Surgery Principal Investigator: Elizabeth VITTE Completed NCT01285921
40 Efficacy of Vestibular Rehabilitation in Patients With Vestibular Migraine Completed NCT03417596
41 A Randomized, Double Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SpotOn Specs™ for the Treatment of Chronic Dizziness Completed NCT01460121
42 A Controlled Clinical Study to Evaluate the Safety and Efficacy of the BrainPort® Balance Device When Used to Improve Balance in Subjects With Peripheral Vestibular Dysfunction Completed NCT00768378
43 the Effect of Vestibular Rehabilitation on Sensory Profile and Postrotary Nistagmus in Austistic Children Completed NCT03957044
44 Study on the Mnemic Functioning of Children With Kabuki Syndrome Completed NCT03547609
45 Vestibular and Multisensory Influence on Bodily and Spatial Representations. Behavioral and Electrophysiological Investigations in Vestibular-defective Patients and Healthy Volunteers Completed NCT01900457
46 Vestibular Rehabilitation for Patients With Fall-related Wrist Fractures - a Randomized Controlled Trial Completed NCT00988572
47 Home-based Computer Gaming in Vestibular Rehabilitation: Effects on Gaze and Balance Impairment Completed NCT01943955
48 The Effects of Local Vibration and Cervical Stabilization Exercises Applied on Neck Muscles on Balance in Healthy Individuals Completed NCT03464214
49 Comparison of Home-Based Modified Self-Epley Manoeuvre and Brandt-Daroff Exercise on the Posterior Canal Benign Paroxysmal Positional Vertigo Symptoms: A Randomized Single-Blind Controlled Trial Completed NCT03230513
50 Clinical Trial Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium Completed NCT01483937

Search NIH Clinical Center for Vestibular Disease

Cochrane evidence based reviews: vestibular diseases

Genetic Tests for Vestibular Disease

Anatomical Context for Vestibular Disease

MalaCards organs/tissues related to Vestibular Disease:

41
Testes, Brain, Eye, Endothelial, Pons, Bone, Spinal Cord

Publications for Vestibular Disease

Articles related to Vestibular Disease:

(show top 50) (show all 382)
# Title Authors PMID Year
1
Recovery of ocular and cervical vestibular evoked myogenic potentials after treatment of inner ear diseases. 38
31070081 2019
2
Comparative study of anti-vertiginous and anti-anxious drugs for the treatment of chronic vestibular patients with secondary anxiety. 38
31107129 2019
3
A decade of magnetic vestibular stimulation: from serendipity to physics to the clinic. 38
30969883 2019
4
[Relationship between the level of estrogen, calcium and phosphorus concentration in serum with benign paroxysmal positional vertigo]. 38
31163520 2019
5
Histamine H4 receptor gene polymorphisms: a potential contributor to Meniere disease. 38
31133025 2019
6
Otitis Media in Childhood and Disease in Adulthood: A 40-Year Follow-Up Study. 38
30998545 2019
7
Risk of traffic accidents after onset of vestibular disease assessed with a surrogate marker. 38
30963255 2019
8
Hearing as an Independent Predictor of Postural Balance in 1075 Patients Evaluated for Dizziness. 38
31013210 2019
9
[The subjective perception of the vertical-a valuable parameter for determination of peripheral vestibular disorder in Menière's disease in the chronic phase?] 38
30725124 2019
10
[Recognizing non-structural vestibular diseases]. 38
30813681 2019
11
Video Head Impulse Test to Preoperatively Identify the Nerve of Origin of Vestibular Schwannomas. 38
29750273 2019
12
Clinical features and short-term outcome of presumptive intracranial complications associated with otitis media/interna: a multi-center retrospective study of 19 cats (2009-2017). 38
29667535 2019
13
Novel Use of Portable Audiometry to Track Hearing Fluctuations in Menière's Disease: A Pilot Study. 38
30614898 2019
14
Inner ear drug delivery: Recent advances, challenges, and perspective. 38
29792920 2019
15
Safety, tolerability, pharmacokinetics and pharmacokinetic-pharmacodynamic modelling of the novel H4 receptor inhibitor SENS-111 using a modified caloric test in healthy subjects. 38
30152527 2018
16
Multicenter data banking in management of dizzy patients: first results from the DizzyNet registry project. 38
29663119 2018
17
Genetic contribution to vestibular diseases. 38
29582143 2018
18
Tone-induced cervical and ocular vestibular-evoked myogenic potentials: comparing abnormalities in traumatic and non-traumatic vestibular disease. 38
30295212 2018
19
Evaluation of Benign Paroxysmal Positional Vertigo in American Football Players. 38
30256203 2018
20
[Advances in peripheral vestibular diseases with downbeat nystagmus]. 38
29986573 2018
21
An attempt to measure the diametric relationship between slow and quick phases of nystagmus. 38
29355067 2018
22
Prevalence and management of post-BPPV residual symptoms. 38
29687182 2018
23
[Etiological characteristics analysis of 3 137 outpatients with vertigo or dizziness in ENT department]. 38
29873213 2018
24
Bilateral tympanokeratomas (cholesteatomas) with bilateral otitis media, unilateral otitis interna and acoustic neuritis in a dog. 38
29788991 2018
25
The Dizziness Handicap Inventory does not correlate with vestibular function tests: a prospective study. 38
29557501 2018
26
Reliability of interpretation of neurologic examination findings for the localization of vestibular dysfunction in dogs. 38
29553894 2018
27
Deafness and vestibular dysfunction in a Doberman Pinscher puppy associated with a mutation in the PTPRQ gene. 38
29460419 2018
28
μVEMP: A Portable Interface to Record Vestibular Evoked Myogenic Potentials (VEMPs) With a Smart Phone or Tablet. 38
30026727 2018
29
Diagnosis of Vertigo and Dizziness Syndromes in a Neurological Outpatient Clinic. 38
29794430 2018
30
Inpatient Treatment of Patients Admitted for Dizziness: A Population-Based Healthcare Research Study on Epidemiology, Diagnosis, Treatment, and Outcome. 38
28938275 2017
31
Survey of systemic antimicrobial prescribing for dogs by Victorian veterinarians. 38
28948625 2017
32
Motion-based equilibrium reprocessing therapy a novel treatment method for chronic peripheral vestibulopathies: A pilot study. 38
28614234 2017
33
The TriAGe+ Score for Vertigo or Dizziness: A Diagnostic Model for Stroke in the Emergency Department. 38
28256416 2017
34
Treating peripheral vestibular disease-associated nausea. 38
28432250 2017
35
Video head impulse test: a review of the literature. 38
27328962 2017
36
[The significance of directional preponderance in the evaluation of vestibular function in patients with vertigo]. 38
28395491 2017
37
An unusual case of peripheral vestibular disease in a cat following ear cleaning. 38
28216690 2017
38
Recent surgical options for vestibular vertigo. 38
29279721 2017
39
Guided and unguided internet-based vestibular rehabilitation versus usual care for dizzy adults of 50 years and older: a protocol for a three-armed randomised trial. 38
28110290 2017
40
Aging with Cerebral Small Vessel Disease and Dizziness: The Importance of Undiagnosed Peripheral Vestibular Disorders. 38
28626444 2017
41
Is Alteration of Tuning Property in Cervical Vestibular-Evoked Myogenic Potential Specific for Ménière's Disease? 38
28533763 2017
42
Computed tomography and magnetic resonance imaging findings for the initial stage of equine temporohyoid osteoarthropathy in a Thoroughbred foal. 38
28955164 2017
43
Vibration-Induced Nystagmus: A Biomarker for Vestibular Deficits - A Synopsis. 38
28231579 2017
44
Gait disorders in the elderly and dual task gait analysis: a new approach for identifying motor phenotypes. 38
28143497 2017
45
[The ultrastructure of utricular maculae of mouse]. 38
28104018 2017
46
Clinical Analysis of Dizzy Patients with High Levels of Depression and Anxiety. 38
27942604 2016
47
10 years of Vertigo Clinic at National Hospital Abuja, Nigeria: what have we learned? 38
26961517 2016
48
The relationship between senile hearing loss and vestibular activity. 38
26997575 2016
49
Chronic subjective dizziness: Analysis of underlying personality factors. 38
27814314 2016
50
How Commonly Is Stroke Found in Patients with Isolated Vertigo or Dizziness Attack? 38
27495834 2016

Variations for Vestibular Disease

Expression for Vestibular Disease

Search GEO for disease gene expression data for Vestibular Disease.

Pathways for Vestibular Disease

Pathways related to Vestibular Disease according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
10.79 GJB6 GJB3 GJB2

GO Terms for Vestibular Disease

Cellular components related to Vestibular Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 apical plasma membrane GO:0016324 9.46 SLC26A4 GJB6 ATP6V1B1 AQP2
2 basolateral plasma membrane GO:0016323 9.43 KCNJ10 ATP6V1B1 AQP2
3 gap junction GO:0005921 9.13 GJB6 GJB3 GJB2
4 connexin complex GO:0005922 8.8 GJB6 GJB3 GJB2

Biological processes related to Vestibular Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 renal water homeostasis GO:0003091 9.32 AVP AQP2
2 regulation of pH GO:0006885 9.26 SLC26A4 ATP6V1B1
3 water transport GO:0006833 9.16 AVP AQP2
4 cell communication GO:0007154 9.13 GJB6 GJB3 GJB2
5 excretion GO:0007588 9.07 ATP6V1B1
6 sensory perception of sound GO:0007605 9.02 SLC26A4 GJB6 GJB2 COCH ATP6V1B1

Molecular functions related to Vestibular Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 gap junction channel activity GO:0005243 8.62 GJB3 GJB2

Sources for Vestibular Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....